Schnellmann R G, Putnam C W, Sipes I G
Biochem Pharmacol. 1983 Nov 1;32(21):3233-9. doi: 10.1016/0006-2952(83)90209-5.
Since the metabolism of polychlorinated biphenyls (PCBs) is the critical factor that determines whether or not they accumulate in adipose tissue, we have studied the metabolism of two hexachlorobiphenyls (HCBs), 2,2'3,3',6,6'-hexachlorobiphenyl (236-HCB) and 2,2'4,4',5,5'-hexachlorobiphenyl (245-HCB), by human hepatic microsomes. Human microsomes were isolated from patients undergoing liver resection and were found to have cytochrome P-450 levels (0.28 nmoles/mg microsomal protein) and cytochrome P-450-dependent enzymatic activities similar to those reported by other workers. 245-HCB was not metabolized by human microsomes under various conditions, while 236-HCB was metabolized with an apparent Km of 8.8 microM and a Vmax of 5.1 pmoles/mg microsomal protein/min. Two major metabolites were formed and identified by gas chromatography-mass spectrometry as 2,2',3,3',6,6'-hexachloro-4-biphenylol and 2,2',3,3'6,6'-hexachloro-5-biphenylol. [14C]236-HCB equivalents were found to covalently bind to microsomal protein. Addition of 1 or 5 mM reduced glutathione decreased the degree of covalent binding. These data suggest that HCBs are metabolized through an arene oxide. The fact that 245-HCB was not metabolized explains why it is the predominant PCB found in human adipose tissue.
由于多氯联苯(PCBs)的代谢是决定它们是否在脂肪组织中蓄积的关键因素,我们研究了两种六氯联苯(HCBs),即2,2',3,3',6,6'-六氯联苯(236-HCB)和2,2',4,4',5,5'-六氯联苯(245-HCB)在人肝微粒体中的代谢情况。人微粒体从接受肝切除手术的患者中分离得到,发现其细胞色素P-450水平(0.28纳摩尔/毫克微粒体蛋白)和细胞色素P-450依赖性酶活性与其他研究者报道的相似。在各种条件下,245-HCB都不被人肝微粒体代谢,而236-HCB被代谢,其表观Km为8.8微摩尔,Vmax为5.1皮摩尔/毫克微粒体蛋白/分钟。形成了两种主要代谢产物,并通过气相色谱-质谱法鉴定为2,2',3,3',6,6'-六氯-4-联苯酚和2,2',3,3',6,6'-六氯-5-联苯酚。发现[14C]236-HCB等价物与微粒体蛋白共价结合。添加1或5毫摩尔的还原型谷胱甘肽可降低共价结合程度。这些数据表明HCBs是通过芳氧化物进行代谢的。245-HCB不被代谢这一事实解释了为什么它是在人体脂肪组织中发现的主要多氯联苯。